Previous studies have revealed the regulatory role of RBMS3 in deactivating the Wnt/β‐catenin signaling pathway and repressing the expressions of diverse genes, including β‐catenin, cyclin D1, and C‐myc, within breast cancer cells.7, 18, 19. Here, RBMS3 is linked to breast carcinoma.